The Neural Underpinnings and the Impact of Wearable Sensory Stimulation During Split-belt Treadmill Adaptation in People With Multiple Sclerosis

CompletedNot a drug-phase studyRelapsing MSNCT05878873

What it found

Met its main goal

The main measure showed a statistically significant benefit.

MeasureEstimate95% CIp
Change in Cortical ActivationMean Difference (Net) -0.0780.007
Change in Cortical ActivationMean Difference (Net) -0.0890.008
Change in Adaptation SavingsMean Difference (Net) 0.04200.014
Rate of Step Length Asymmetry AdaptationMean Difference (Final Values) -0.0080.698
Change in Adaptation SavingsMean Difference (Net) -0.00580.878
Rate of Step Length Asymmetry AdaptationMean Difference (Final Values) 0.0020.898

Statistical analysis as posted on ClinicalTrials.gov.

What was tested

Treatment tested

  • Transcutaneous Electrical Nerve Stimulation (TENS)

Given to everyone in the trial

  • Split-belt Treadmill

Results by group

Change in Cortical Activation

Training session 1 (day 1), training session 2 (day 28)

GroupValueIntervalNumber analysed
Split-belt Treadmill Training Without TENS0.054 Unitless GLM beta weight (HbO)0.021 (Standard Error)48
Split-belt Treadmill Training With TENS-0.024 Unitless GLM beta weight (HbO)0.021 (Standard Error)48
Split-belt Treadmill Training Without TENS0.074 Unitless GLM beta weight (HbO)0.025 (Standard Error)48
Split-belt Treadmill Training With TENS-0.016 Unitless GLM beta weight (HbO)0.025 (Standard Error)48

Split-belt Treadmill Training Without TENS

0.054

Split-belt Treadmill Training With TENS

-0.024

Split-belt Treadmill Training Without TENS

0.074

Split-belt Treadmill Training With TENS

-0.016

p = 0.007; Mean Difference (Net) -0.078

Change in Adaptation Savings

Training session 1 (day 1), training session 2 (day 28)

GroupValueIntervalNumber analysed
Split-belt Treadmill Training With TENS First0.0032 Unitless Relative Step Length Asymmetry0.0103 (Standard Error)22
Split-belt Treadmill Training With TENS Second0.0451 Unitless Relative Step Length Asymmetry0.0096 (Standard Error)26
Split-belt Treadmill Training With TENS First0.0221 Unitless Relative Step Length Asymmetry0.0124 (Standard Error)22
Split-belt Treadmill Training With TENS Second0.0278 Unitless Relative Step Length Asymmetry0.0112 (Standard Error)26

Split-belt Treadmill Training With TENS First

0.0032

Split-belt Treadmill Training With TENS Second

0.0451

Split-belt Treadmill Training With TENS First

0.0221

Split-belt Treadmill Training With TENS Second

0.0278

p = 0.014; Mean Difference (Net) 0.0420

Rate of Step Length Asymmetry Adaptation

Training session 1 (day 1)

GroupValueIntervalNumber analysed
Split-belt Treadmill Training Without TENS-0.090 Unitless Relative Step Length Asymmetry0.012 (Standard Error)26
Split-belt Treadmill Training With TENS-0.088 Unitless Relative Step Length Asymmetry0.013 (Standard Error)22
Split-belt Treadmill Training Without TENS-0.095 Unitless Relative Step Length Asymmetry0.014 (Standard Error)26
Split-belt Treadmill Training With TENS-0.103 Unitless Relative Step Length Asymmetry0.016 (Standard Error)22

Split-belt Treadmill Training Without TENS

-0.09

Split-belt Treadmill Training With TENS

-0.088

Split-belt Treadmill Training Without TENS

-0.095

Split-belt Treadmill Training With TENS

-0.103

p = 0.898; Mean Difference (Final Values) 0.002

Values as posted on ClinicalTrials.gov. Outcomes measured differently across trials are not directly comparable.

Safety

GroupParticipants at riskSerious adverse eventsDeaths
Split-belt Treadmill Training With TENS: People With Multiple Sclerosis290 (0.0%)0
Split-belt Treadmill Training Without TENS: People With Multiple Sclerosis290 (0.0%)0
Split-belt Treadmill Training With TENS: Healthy Controls200 (0.0%)0
Split-belt Treadmill Training Without TENS: Healthy Controls200 (0.0%)0

As posted on ClinicalTrials.gov. Serious adverse events include any serious health event during the trial, whether or not the treatment caused it.

What it measured

Main measures

  • Change in Cortical Activation

    Training session 1 (day 1), training session 2 (day 28)

    Brain volume lossWalking and mobilityNerve conduction tests
  • Change in Adaptation Savings

    Training session 1 (day 1), training session 2 (day 28)

    Walking and mobilityFeasibility
  • Rate of Step Length Asymmetry Adaptation

    Training session 1 (day 1)

    Bladder, bowel and sexual function

Who could take part

Relapsing MS · 18 to 86

Show the full criteria

Inclusion criteria

* A diagnosis of relapsing remitting multiple sclerosis OR a neurotypical adult (ages 18-86) * Not experiencing an active relapse * Able to stand and walk without an assistive device * Able to walk for three tenths of a mile without stopping to rest

Exclusion criteria

* Unable to walk for three tenths of a mile without assistance * Musculoskeletal injury in past 6 months * Lower extremity surgery in past 6 months * Unable to abstain from medications that impair balance * Currently pregnant * History of traumatic brain injury * History of vestibular disease * History of any other balance impairment unrelated to multiple sclerosis

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Majority of people with multiple sclerosis experience difficulty with balance and mobility, leading to an increased risk of falls. The goal of this clinical trial is to learn about brain activity during walking adaptation in people with multiple sclerosis. Also, this clinical trial will test a form of nerve stimulation to see if it can improve walking performance. The main questions it aims to answer are: * What areas of the brain are the most active during walking adaptation? * Can nerve stimulation make walking adaptation more effective? Participants will walk on a treadmill where each leg will go a different speed which will create walking adaptation. At the same time, brain scans will occur. There will be two sessions of walking adaptation, one with nerve stimulation, and one without nerve stimulation. Researchers will compare people with multiple sclerosis to healthy young adults to see if there are differences in brain activity.

Papers

Loading reviews and guidelines…

History

    1. Started

      Nov 2023

    2. Main results due

      Jun 2024

    3. Finished

      Jun 2024

    4. Results posted

      Jul 2025

    Assembled by software from public sources.